ModMed | AI Transformation Index
ModMed is a rare healthcare SaaS asset that sits on the right side of AI disruption: it is the system-of-record infrastructure through which AI must operat...

Overview
ModMed sells specialty-specific cloud EHR, practice management, RCM, and patient engagement software to ambulatory medical practices on a recurring subscription model, supplemented by implementation and revenue cycle services.
Executive Summary
ModMed is a rare healthcare SaaS asset that sits on the right side of AI disruption: it is the system-of-record infrastructure through which AI must operate rather than a service that AI replaces. The structural protection from healthcare regulation, the near-unbreakable switching costs of a specialty-configured clinical platform, and the irreplaceable specialty clinical data corpus combine to make ModMed's position more defensible in an AI world than before it. At the same time, the AI opportunity is exceptional — the platform touches nearly every cognitive workflow in ambulatory practice, owns the data needed to build genuinely superior specialty AI, and can expand its monetizable surface area substantially through AI-enabled products that practices will pay incrementally for.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
81.0
Ciridae AI Score
Durability Rationale
ModMed's durability rests on three mutually reinforcing foundations: it is the regulatory system-of-record that practices legally must maintain, it is structurally un-bypassable as the operational control plane for clinical and financial workflows, and it is protected from rapid AI-native entry by healthcare's exceptional certification and compliance requirements. The combination of deep switching costs — spanning clinical records, billing history, specialty configuration, and staff workflows — with regulatory moats and system-of-record status makes ModMed one of the more structurally durable positions in healthcare technology. AI strengthens rather than threatens the platform because every AI capability in ambulatory care needs a certified, integrated substrate to operate on.
Opportunity Rationale
AI is a transformative opportunity for ModMed precisely because its platform sits at the intersection of the most AI-amenable workflows in healthcare — documentation, coding, denial management, patient communication — while owning the specialty-specific clinical data corpus needed to make AI genuinely superior to generic alternatives. The magnitude of improvement in physician documentation alone is exceptional, and the expansion into agentic patient engagement and AI-assisted RCM opens new addressable market segments and value layers that weren't economically viable before. The domain intelligence asset — 500 million specialty interactions — is the amplifier that could make ModMed's AI capabilities defensibly superior to any competitor lacking equivalent specialty depth.
Key Risks
A major EHR platform with a larger installed base (Epic, athenahealth) aggressively prices specialty-specific AI capabilities into their existing contracts, neutralizing ModMed's differentiation and triggering churn from larger specialty practices that accept workflow compromises in exchange for a unified enterprise health system relationship.
The AI opportunity thesis depends on ModMed's specialty data remaining a defensible moat, but if foundation model providers train on broadly licensed clinical data or if competitors aggregate comparable specialty datasets through acquisitions, ModMed's AI advantage compresses to a product execution race rather than a data-structural advantage.
Company Overview
| Headquarters | Boca Raton, Florida, United States |
| Products / Services | Specialty-specific EHRs including EMA and gGastropractice managementrevenue cycle management and billing servicespatient engagement and communication through Klarapayment processinganalyticsmarketingintegrationsand AI products including ModMed Scribe and AI workflow assistants. |
| Deal Partners |
AI & Tech Initiatives
| Name | Description |
|---|---|
| ModMed Scribe | Ambient listening and generative clinical documentation natively integrated into the EMA EHR. It captures provider-patient conversation, generates specialty-aware clinical notes, suggests billing codes, and pre-populates downstream actions such as medications, labs, prescriptions, and patient education. |
| ModMed Scribe for Dermatology | A dermatology-specific generative-AI ambient documentation solution trained on de-identified specialty data from more than 500 million patient-provider interactions. It generates notes and structured outputs and supports billing-code suggestions and downstream workflow completion. |
| ModMed Scribe 2.0 | An upgraded ambient-AI product using proprietary specialty-trained models and large de-identified clinical datasets. Scribe 2.0 interprets natural dialogue, creates clinically relevant notes, connects diagnoses and treatments, and supports follow-on clinical actions. |
| ModMed Billing Assistant | A generative-AI workflow assistant intended to guide claim correction, suggest denial reasons and resolution actions, and learn from payer-specific historical claim interactions in conjunction with ModMed’s RCM services. |
| ModMed Front Office Assistant | An agentic workflow assistant under development to analyze patient communications and practice data, propose actions, and execute approved multi-step workflows for messaging, scheduling, and intake coordination. |
| ModMed Clinical Assistant | An AI assistant planned to summarize a patient’s recent history, demographics, labs, pathology, radiology, and prior visits before the clinical encounter for provider review. |
| Bonsai Health agentic patient engagement | An agentic AI patient-engagement capability acquired through Bonsai Health. It identifies care gaps and schedule openings, then uses SMS and email to automate patient reactivation and self-scheduling without manual staff intervention. |
PE / Ownership History
| Event | Details |
|---|---|
Acquired Bonsai Health April 20, 2026 | ModMed acquired Bonsai Health, an agentic-AI patient-engagement platform. Financial terms were not disclosed. Bonsai’s founders Travis Schneider and Luke Kervin joined the ModMed family; the technology is intended to scale across nearly 50,000 providers. |
Clearlake Capital majority investment; Warburg Pincus exited control April 30, 2025 | Clearlake completed a majority investment in ModMed, succeeding Warburg Pincus as the controlling financial sponsor. Financial terms were not disclosed by ModMed; contemporaneous reporting valued the company at approximately $5.3 billion including debt. Clearlake cited its O.P.S. framework and plans to accelerate growth, innovation, and AI-enabled software. |
Acquired Xtract Solutions allergy software January 5, 2023 | ModMed acquired Xtract Solutions’ allergy testing and immunotherapy software to expand its allergy, asthma, and immunology platform. |
Acquired Klara February 8, 2022 | ModMed acquired Klara, a patient communication and collaboration platform, to strengthen digital patient engagement and connect communications with EHR and practice-management workflows. |
Acquired TRAKnet assets April 16, 2021 | Modernizing Medicine acquired TRAKnet and related assets from NEMO Health to expand its podiatry offering. |
Acquired Exscribe January 12, 2021 | Modernizing Medicine acquired orthopedic EHR vendor Exscribe; Exscribe founder Dr. Ranjan Sachdev and team joined ModMed. |
Warburg Pincus $231 million equity investment and ownership transition May 10, 2017 | Warburg Pincus invested $231 million, providing liquidity to existing shareholders, funding expansion, and supporting strategic initiatives. Fred Hassan joined the board; Amr Kronfol also joined the board. Andrew Park commented on the transaction but was a Principal and is therefore not included under the requested seniority rule. |
Acquired gMed September 1, 2015 | Modernizing Medicine completed its acquisition of gMed, adding gastroenterology EHR, endoscopy reporting, practice management, patient portal, analytics, and RCM capabilities. |
Acquired Aesyntix Health December 22, 2014 | Modernizing Medicine completed the acquisition of Aesyntix Health, adding specialty revenue-cycle management, inventory management, and group purchasing services. |
Summit Partners equity investment November 2014 | Modernizing Medicine completed an additional equity round associated with Summit Partners; transaction-specific senior deal personnel were not identified. |
Summit Partners growth investment August 20, 2013 | An early growth-equity round associated with Summit Partners; no qualifying senior Summit deal partner was identified in the available announcement materials. |
Pentland Group equity investment December 5, 2012 | Pentland Group provided an early equity investment; publicly available deal materials identify the investor but not a qualifying named senior deal partner. |
Executives
| Name | Background |
|---|---|
Daniel Cane Co-Chief Executive Officer and Co-Founder | Co-founded ModMed in 2010; previously co-founded Blackboard and is a healthcare-technology entrepreneur. |
Joe Harpaz Co-Chief Executive Officer | Previously Managing Director of the Corporate Market at Thomson Reuters; founded Immediatech and the GoFileRoom cloud workflow business. Joined ModMed as President and COO in 2018 and became co-CEO in 2024. |
Dr. Michael Sherling Chief Medical and Strategy Officer and Co-Founder | Co-founded ModMed; physician and dermatologist. Previously Associate Director of Laser Medicine and Skin Health at Brigham and Women’s Hospital and Associate Residency Program Director at Harvard Medical School. |
Michelle Scheer Chief Financial Officer | Previously CFO for Tax & Accounting at Thomson Reuters and held treasury and finance roles at General Motors. |
Jody Beaverson Chief People Officer | Previously SVP of People at Change Healthcare. |
Joe Ashkouti Chief Legal Officer | Previously Deputy General Counsel and Chief Privacy Officer at Change Healthcare; held legal roles at McKesson and WebMD. |
Celine Kaiser Chief Customer Officer | Previously executive at Merchant Link and held strategic roles at Amadeus, Capgemini, Wanadoo, and Ernst & Young. |
Stephen Foster Chief Revenue Officer | Previously EVP for Global Accounts and Americas Sales at Qlik, EVP at Attunity, and held management roles at Oracle. |
Justin Steinman Chief Marketing Officer | Previously CMO at Ensora Health and Definitive Healthcare; Head of Commercial Product and Solutions at Aetna; CMO at GE Healthcare Digital; earlier roles at Novell and Accenture. |
Carlos Fuentes Chief Information Security Officer | Previously CISO at Pegasystems; held technology leadership roles at the Federal Reserve Bank of New York, Verizon, and Mitsui Sumitomo Insurance. |
Irish McIntyre Chief Product Officer | Previously held roles at Thomson Reuters, Lotus, and IBM. |
Jill Girardeau Chief Compliance Officer | Previously Chief Regulatory Counsel at Change Healthcare and Deputy General Counsel at Optum Insight. |
Anthony Grabenau Chief Accounting Officer | Previously Chief Accounting Officer at Jamf and held finance roles at Verizon, TopBuild, and Hard Rock International. |
Dr. Tomer Lancewicki Vice President of AI and Machine Learning | Previously Director of AI and Machine Learning at Walmart Global Tech, with earlier technology leadership roles at eBay and LiveIntent. Holds a PhD in Electrical and Computer Engineering, twelve patents, and is an adjunct machine-learning professor at Northeastern University. |
Clearlake Capital Group